Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07133802 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-Vaccination

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 21, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
A Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-Vaccination
Trial Details
NCT Number NCT07133802
Lead Sponsor Changchun BCHT Biotechnology Co.
Collaborators: Hebei Provincial Center for Disease Control and Prevention, Center for Disease Control and Prevention, Fujian, Zhejiang Provincial Center for Disease Control and Prevention
Conditions
(from sponsor)		 Prevention of Influenza
Enrollment 6,680 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov